Skip to content

A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Dynamic Radial Cheek Line Skin Depressions

BEAM: Prospective Open Label Study to Evaluate the Effectiveness of Juvéderm® VOLIFT®™ With Lidocaine for Treatment of Dynamic Radial Cheek Line Skin Depressions

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02980783
Acronym
BEAM
Enrollment
53
Registered
2016-12-02
Start date
2016-10-13
Completion date
2016-12-14
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cheek Line Depressions

Brief summary

This study will evaluate the effectiveness of Juvéderm® VOLIFT®™ with Lidocaine for dynamic radial cheek line skin depressions.

Interventions

DEVICEJuvéderm® VOLIFT®™ with Lidocaine

Juvéderm® VOLIFT®™ (hyaluronic acid) with Lidocaine is injected into the dynamic radial cheek line skin depressions on Day 1; volume of injection will not exceed 2 mL per side. If applicable, a touch-up of Juvéderm® VOLIFT®™ with Lidocaine will be injected on Day 14; volume will not exceed 1 mL per side.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Presence of dynamic radial cheek lines * Agrees not to make any changes to skin care routines, or to have any facial procedures or treatments during the study

Exclusion criteria

* Previous facial surgery, tissue grafting, or tissue augmentation with silicone, fat, or other permanent, or semi-permanent dermal fillers or be planning to undergo any of these procedures during the study * Undergone temporary facial dermal filler injections with any substance in the face in the 12 months prior to study entry * Received botulinum toxin therapy of any serotype in any facial area within the previous 6 months agrees not to receive it during the study

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS)Baseline (Day 1) to Day 45Participants graded the improvement of their dynamic radial cheek lines using the GAIS 5-point scale where -2=much worse to +2=much improved. Participants who rated their improvement as -2, -1, or 0 (much worse, worse, or no change, respectively) were grouped as Not Improved and those who rated their improvement as +1 or +2 (improved or much improved, respectively) were grouped as Improved. The percentages of participants who rated their cheek lines as Improved and Not Improved are reported.

Secondary

MeasureTime frameDescription
Change From Baseline in Mean Texture (Rz) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1) to Day 45The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers. A negative change from Baseline (pre-treatment) indicates that the texture of wrinkles improved.
Change From Baseline in Mean Amplitude (Rt) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1) to Day 45The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers. A negative change from Baseline (pre-treatment) indicates that the amplitude of wrinkles decreased.
Change From Baseline in Wrinkle Volume of Radial Cheek Lines at Maximum SmileBaseline (Day 1) to Day 45
Change From Baseline in Mean Roughness (Ra) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1) to Day 45The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers (μm). A negative change from Baseline (pre-treatment) indicates that the roughness of wrinkles decreased.
Percentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireBaseline (Day 1) to Day 45The SPA questionnaire consists of one question: How do you think your facial appearance looks compared to your age TODAY? Participants could choose one of three possible answers: I look my current age, I look younger, or I look older. The percentage of participants in the following SPA categories is reported: I look my current age, I look younger and I look older.
Mean Score for the Level of Naturalness of the Appearance of Participants' Dynamic Radial Cheek Lines as Assessed by a Participant QuestionnaireDay 45Participants were asked to indicate their level agreement with the following statement: The treatment of my smile lines gave me a natural look. Responses were scored from 0 to 10, where 0=not at all to 10=very much.
Percentage of Participants by Improvement Rating (Response) of the Participants' Dynamic Radial Cheek Lines as Assessed by the Investigator Using the GAISBaseline (Day 1) to Day 45The investigator graded the improvement of the participant's dynamic radial cheek lines on both sides of their face using the 5-point GAIS where -2=much worse to +2=much improved. Responders are participants with a score of +1 or +2 (improved or much improved, respectively) on both sides; partial responder are participants with a score of +1 or +2 on only one side; and no-responders are participants with a score lower or equal to 0 on both sides. The percentages of responders, partial responders, and no-responders are reported.

Countries

France

Participant flow

Participants by arm

ArmCount
Juvéderm® VOLIFT®™ With Lidocaine
Juvéderm® VOLIFT®™ (hyaluronic acid) with Lidocaine was injected into the dynamic radial cheek line skin depressions on Day 1; volume was determined by the investigator. If applicable, a touch-up of Juvéderm® VOLIFT®™ with Lidocaine was injected on Day 14.
53
Total53

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicJuvéderm® VOLIFT®™ With Lidocaine
Age, Continuous56 years
STANDARD_DEVIATION 7
Sex: Female, Male
Female
53 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
31 / 53
serious
Total, serious adverse events
0 / 53

Outcome results

Primary

Percentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS)

Participants graded the improvement of their dynamic radial cheek lines using the GAIS 5-point scale where -2=much worse to +2=much improved. Participants who rated their improvement as -2, -1, or 0 (much worse, worse, or no change, respectively) were grouped as Not Improved and those who rated their improvement as +1 or +2 (improved or much improved, respectively) were grouped as Improved. The percentages of participants who rated their cheek lines as Improved and Not Improved are reported.

Time frame: Baseline (Day 1) to Day 45

Population: Per Protocol Population included all participants with no major protocol deviations.

ArmMeasureGroupValue (NUMBER)
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS)Improved98.1 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS)Not Improved1.9 percentage of participants
Secondary

Change From Baseline in Mean Amplitude (Rt) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®

The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers. A negative change from Baseline (pre-treatment) indicates that the amplitude of wrinkles decreased.

Time frame: Baseline (Day 1) to Day 45

Population: Safety Population included all participants who used the test product at least once. Number analyzed is the number of participants with available data at the given time-point.

ArmMeasureGroupValue (MEAN)Dispersion
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Amplitude (Rt) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1)511.8 μmStandard Deviation 217.8
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Amplitude (Rt) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Change from Baseline at Day 45-115.1 μmStandard Deviation 129.4
Secondary

Change From Baseline in Mean Roughness (Ra) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®

The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers (μm). A negative change from Baseline (pre-treatment) indicates that the roughness of wrinkles decreased.

Time frame: Baseline (Day 1) to Day 45

Population: Safety Population included all participants who used the test product at least one time. Number analyzed is the number of participants with available data at the given time-point.

ArmMeasureGroupValue (MEAN)Dispersion
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Roughness (Ra) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1)96.6 μmStandard Deviation 53.6
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Roughness (Ra) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Change from Baseline at Day 45-24.8 μmStandard Deviation 31.9
Secondary

Change From Baseline in Mean Texture (Rz) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®

The DERMATOP® is a fringe projection system used to measure wrinkles. The system collects 2-dimensional (2D) and 3-dimensional (3D) images and then calculates the roughness, texture, and amplitude of wrinkles. To ensure that repeat measurements are made in the same area, the angles of the camera were recorded, and a red positioning laser was used to mark the edge of the chin. In addition, a 2D picture of the baseline measurements was taken by the machine to position subsequent measurements. Measurements are presented in micrometers. A negative change from Baseline (pre-treatment) indicates that the texture of wrinkles improved.

Time frame: Baseline (Day 1) to Day 45

Population: Safety Population included all participants who used the test product at least once. Number analyzed is the number of participants with available data at the given time-point.

ArmMeasureGroupValue (MEAN)Dispersion
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Texture (Rz) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Baseline (Day 1)203.1 μmStandard Deviation 72.3
Juvéderm® VOLIFT®™ With LidocaineChange From Baseline in Mean Texture (Rz) of the Radial Cheek Lines at Maximum Smile as Assessed by DERMATOP®Change from Baseline at Day 45-35.3 μmStandard Deviation 43.6
Secondary

Change From Baseline in Wrinkle Volume of Radial Cheek Lines at Maximum Smile

Time frame: Baseline (Day 1) to Day 45

Population: No data was collected because wrinkle volume was not applicable.

Secondary

Mean Score for the Level of Naturalness of the Appearance of Participants' Dynamic Radial Cheek Lines as Assessed by a Participant Questionnaire

Participants were asked to indicate their level agreement with the following statement: The treatment of my smile lines gave me a natural look. Responses were scored from 0 to 10, where 0=not at all to 10=very much.

Time frame: Day 45

Population: Per Protocol Population included all participants with no major protocol deviations.

ArmMeasureValue (MEAN)Dispersion
Juvéderm® VOLIFT®™ With LidocaineMean Score for the Level of Naturalness of the Appearance of Participants' Dynamic Radial Cheek Lines as Assessed by a Participant Questionnaire7.2 units on a scaleStandard Deviation 2.2
Secondary

Percentage of Participants by Improvement Rating (Response) of the Participants' Dynamic Radial Cheek Lines as Assessed by the Investigator Using the GAIS

The investigator graded the improvement of the participant's dynamic radial cheek lines on both sides of their face using the 5-point GAIS where -2=much worse to +2=much improved. Responders are participants with a score of +1 or +2 (improved or much improved, respectively) on both sides; partial responder are participants with a score of +1 or +2 on only one side; and no-responders are participants with a score lower or equal to 0 on both sides. The percentages of responders, partial responders, and no-responders are reported.

Time frame: Baseline (Day 1) to Day 45

Population: Per Protocol Population included all participants with no major protocol deviations.

ArmMeasureGroupValue (NUMBER)
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Improvement Rating (Response) of the Participants' Dynamic Radial Cheek Lines as Assessed by the Investigator Using the GAISResponder94.2 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Improvement Rating (Response) of the Participants' Dynamic Radial Cheek Lines as Assessed by the Investigator Using the GAISPartial Responder1.9 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Improvement Rating (Response) of the Participants' Dynamic Radial Cheek Lines as Assessed by the Investigator Using the GAISNo Responder3.8 percentage of participants
Secondary

Percentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) Questionnaire

The SPA questionnaire consists of one question: How do you think your facial appearance looks compared to your age TODAY? Participants could choose one of three possible answers: I look my current age, I look younger, or I look older. The percentage of participants in the following SPA categories is reported: I look my current age, I look younger and I look older.

Time frame: Baseline (Day 1) to Day 45

Population: Safety Population included all participants who used the test product at least one time. Number analyzed is the number of participants with available data at the given time-point.

ArmMeasureGroupValue (NUMBER)
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireBaseline (Day) 1: I look my current age53 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireBaseline (Day) 1: I look younger28 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireBaseline (Day) 1: I look older19 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireDay 45: I look my current age38 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireDay 45: I look younger60 percentage of participants
Juvéderm® VOLIFT®™ With LidocainePercentage of Participants by Self-Perceived Age Category as Assessed by the Self-Perception of Age (SPA) QuestionnaireDay 45: I look older2 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026